Pharmaceutical Patent Doctrine of Equivalents Survives Challenge

by Editor

Abraxis (AstraZeneca) v. Mayne (Fed. Cir. 2006).

Mayne
http://feeds.feedburner.com/~r/PatentlyObv…

Technorati Tags: patent, law

"Pharmaceutical Patent Doctrine of Equivalents Survives Challenge" was published on November 17th, 2006 and is listed in Patent Law.

Follow comments via the RSS Feed | Leave a comment | Trackback URL

Leave Your Comment

You must be logged in to post a comment.

Site Info
- Home
- Archives
Search

Search:
Categories
Daily Archive
- November 2008
  
  M T W T F S S
  
  « May
  
  1 2
  
  3 4 5 6 7 8 9
  
  10 11 12 13 14 15 16
  
  17 18 19 20 21 22 23
  
  24 25 26 27 28 29 30
Monthly Archives
Meta
- Syndicate
- RSS 2.0 Feed
- Atom Feed
- Comments RSS Feed
- Login

November 2008
M	T	W	T	F	S	S
« May
	1	2
3	4	5	6	7	8	9
10	11	12	13	14	15	16
17	18	19	20	21	22	23
24	25	26	27	28	29	30

The information provided on this Website is for informational purposes only. It does not constitute legal advice nor does it necessarily reflect the opinion of PatentLawPortal.com. There is no implicit guarantee that this information is correct, complete, or up-to-date. PatentLawPortal.com is not intended to create an attorney-client relationship between you and PatentLawPortal.com. You should not act or rely on any information in this Website without seeking the advice of an attorney.

PatentLawPortal

Pharmaceutical Patent Doctrine of Equivalents Survives Challenge

Leave Your Comment

Site Info

Search

Categories

Daily Archive

Monthly Archives

Meta

Syndicate